Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neuroblastoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Endometrial Neoplasms 2 Congenital Abnormalities 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pain 1 Neurofibrosarcoma 1 Neoplasms 1 Myeloproliferative Syndrome, Transient 1 Meningioma 1 Melanoma 1 Malignant mesenchymal tumor 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Eosinophilic, Acute 1

Interventions

Radiotherapy 2 Psychiatric Rehabilitation 2 Hydroxyurea 2 lutetium Lu 177 dotatate 1 emvododstat 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Proton Therapy 1 Octreotide 1 Observation 1 Mifepristone 1 Ifosfamide 1 Everolimus 1 Chemotherapy, Adjuvant 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Meningioma × Observation × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡